Which factor significantly influences distribution of some drugs into pigmented tissues, affecting volume of distribution?

Which factor significantly influences distribution of some drugs into pigmented tissues, affecting volume of distribution?

• A. Binding to Melanin in Tissues
• B. Rapid Renal Excretion
• C. Low Protein Binding in Plasma
• D. Weak Acid–Base Interactions in Blood

Answer: (A)

Binding to melanin in tissues is what drives drugs to accumulate in pigmented sites like the eye and skin. Melanin provides binding sites that trap certain drugs, so a portion of the drug is sequestered in these tissues rather than staying free in plasma. This sequestration raises the apparent volume of distribution because a larger amount of drug is residing in tissues rather than in blood or lean body water, and it can also slow down clearance as the drug slowly leaks back into circulation. The effect is especially noticeable for drugs with an affinity for melanin and sufficient lipophilicity to reach pigmented tissues. Other factors described don’t specifically explain pigment-tissue distribution. Rapid renal excretion reduces overall systemic exposure and clearance but doesn’t promote tissue sequestration in pigmented tissues. Low protein binding in plasma increases the free fraction overall but doesn’t account for selective melanin binding. Weak acid–base interactions affect distribution via ionization and partitioning, but they don’t account for the selective binding to pigmented tissue melanin that drives this distribution behavior.

Binding to melanin in tissues is what drives drugs to accumulate in pigmented sites like the eye and skin. Melanin provides binding sites that trap certain drugs, so a portion of the drug is sequestered in these tissues rather than staying free in plasma. This sequestration raises the apparent volume of distribution because a larger amount of drug is residing in tissues rather than in blood or lean body water, and it can also slow down clearance as the drug slowly leaks back into circulation. The effect is especially noticeable for drugs with an affinity for melanin and sufficient lipophilicity to reach pigmented tissues.

Other factors described don’t specifically explain pigment-tissue distribution. Rapid renal excretion reduces overall systemic exposure and clearance but doesn’t promote tissue sequestration in pigmented tissues. Low protein binding in plasma increases the free fraction overall but doesn’t account for selective melanin binding. Weak acid–base interactions affect distribution via ionization and partitioning, but they don’t account for the selective binding to pigmented tissue melanin that drives this distribution behavior.